title: Carboplatin for early triple-negative breast cancer?
authors.affiliation: University of Texas MD Anderson Cancer Center, Department of Breast Medical Oncology, Houston, TX 77030, USA. Electronic address: vvalero@mdanderson.org.
authors.forename: Vicente
authors.initials: V
authors.lastname: Valero
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D016190:Carboplatin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D020360:Neoadjuvant Therapy; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis*; D064726:Triple Negative Breast Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D016190:Carboplatin; D018719:Erb-b2 Receptor Tyrosine Kinases; C508053:ERBB2 protein, human